Juno Therapeutics, Inc. 4
4 · Juno Therapeutics, Inc. · Filed Jun 21, 2016
Insider Transaction Report
Form 4
Levitsky Hyam
See Remarks
Transactions
- Sale
Common Stock
2016-06-17$42.76/sh−12,118$518,121→ 117,000 total - Sale
Common Stock
2016-06-17$43.20/sh−300$12,960→ 116,700 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $42.195 to $43.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2016.